Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA - Drug Trials For Money - Paid Clinical Trials

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
Condition:   Myelodysplastic Syndromes
Interventions:   Drug: Canakinumab Injection;   Drug: Darbepoetin Alfa
Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Novartis Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 16, 2021 / by / in
Comments